135248-89-4

Basic information

• Product Name: Fmoc-L-Cysteine
• Synonyms: (R)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-3-Mercaptopropanoic acid;N-FMoc-L-cysteine;Fmoc-cysteine;N-(9-Fluorenylmethoxycarbonyl)-L-cysteine;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-cysteine;Fmoc-L-cysteine hydrate≥ 98% (HPLC);(9H-Fluoren-9-yl)MethOxy]Carbonyl Cys-OH
• CAS NO: 135248-89-4
• Molecular Formula: C₁₈H₁₇NO₄S
• Molecular Weight: 343.39688
• Mol File: 135248-89-4.mol
• Article Data: 44

Chemical Properties

• Boiling Point: 574.4±50.0 °C(Predicted)
• Appearance: /
• Density: 1.337±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C(protect from light)
• Solubility: Acetone (Slightly), DMF (Slightly), DMSO (Slightly), Methanol (Slightly, Heated)
• PKA: 3.45±0.10(Predicted)
• CAS DataBase Reference: Fmoc-L-Cysteine(CAS DataBase Reference)
• NIST Chemistry Reference: Fmoc-L-Cysteine(135248-89-4)
• EPA Substance Registry System: Fmoc-L-Cysteine(135248-89-4)

Safety Data

• Hazardous Substances Data: 135248-89-4(Hazardous Substances Data)

Usage

Chemical Properties

White crystalline powder

Uses

N-Fmoc-L-cysteine is the N-Fmoc-protected form of L-Cysteine (C995000), a non-essential α-amino acid that is biosynthesized in humans. L-Cysteine is also a bicarbonate-sensitive endogenous excitotoxin in rats and possibly humans.

Upstream product

• 82911-69-1 N-(9H-fluoren-2-ylmethoxycarbonyloxy)succinimide 
• 1431430-16-8 C₃₇H₃₁N₃O₈S 
• 28920-43-6 (fluorenylmethoxy)carbonyl chloride 
• 52-90-4 L-Cysteine 
• 1131148-55-4 1-[(9-fluorenylmethyloxycarbonyl)]benzotriazole 
• 1227363-07-6 (LGACAGL)2 
• 1227363-09-8 (AACAA)2 
• 167015-11-4 Fmoc-D-Cys(Trt)-OH 
• 1031721-24-0 (S)-{{7-[bis(carboxymethyl)amino]coumarin-4-yl}methyloxycarbonyl}-N-Fmoc-L-cysteine 
• 103213-32-7 N-(9-fluorenylmethoxycarbonyl)-S-trityl-L-cysteine 
• 135273-01-7 N,N'-bis[(9H-fluoren-9-ylmethoxy)carbonyl]-L-cystine 
• 1403834-73-0 C₂₆H₂₅NO₆S₂ 

Downstream Products

• 186829-25-4 N^α-(9-fluorenylmethyloxycarbonyl)-S-(9H-xanthen-9-yl)cysteine 
• 915023-47-1 cyclo[2,7]-AoxAc-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-Thr-OH 
• 210883-65-1 (L)-2-(9H-fluoren-9-ylmethoxycarbonyl)-3-octylsulfanyl-propionic acid 
• 73724-43-3 3-[(1,1-dimethylethyl)dithio]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanine 
• 527685-78-5 L-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(phenyldisulfanyl)propanoic acid 
• 1208242-13-0 L-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(ethyldisulfanyl)propanoic acid 
• 1385775-57-4 N-Fmoc-L-Cys(S-(4-OMe-Bz))-OH 
• 1459764-61-4 C₄₁H₄₂N₄O₁₂S 

Relevant articles and documents

Peptide Tethering: Pocket-Directed Fragment Screening for Peptidomimetic Inhibitor Discovery

Constrained peptides have proven to be a rich source of ligands for protein surfaces, but are often limited in their binding potency. Deployment of nonnatural side chains that access unoccupied crevices on the receptor surface offers a potential avenue to

Disulfide-Based Protecting Groups for the Cysteine Side Chain

Two new disulfide-based protecting groups (SIT and MOT) are proposed for Cys thiol in the substitution of StBu, which is often difficult to remove. Both groups are based on a secondary thiol with a branched point in the β-position for an efficient modulat

VERSATILE PEPTIDE AND PROTEIN MACROCYCLIZATION AND MULTIMERIZATION WITH DIELS-ALDER CYCLOADDITIONS

The present disclosure provides macrocyclic and macrobicyclic peptides with secondary structures that are stabilized over the corresponding non-cyclic peptides. The macrocyclic and macrobicyclic peptides are formed from peptides with adduct-forming, compl